Cargando…
A potential biomarker based on clinical-radiomics nomogram for predicting survival and adjuvant chemotherapy benefit in resected node-negative, early-stage lung adenocarcinoma
BACKGROUND: We aimed to construct a clinical-radiomics nomogram to predict disease-free survival (DFS) and the added survival benefit of adjuvant chemotherapy (ACT) for node-negative, early-stage (I–II) lung adenocarcinoma (ADC). METHODS: In this retrospective study including 310 patients from two i...
Autores principales: | Ma, Xiaoling, Lv, Wenzhi, Wang, Cong, Tu, Dehao, Qiao, Jinhan, Fan, Chanyuan, Niu, Jiandong, Zhou, Wen, Liu, Qiuyu, Xia, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828517/ https://www.ncbi.nlm.nih.gov/pubmed/35242363 http://dx.doi.org/10.21037/jtd-21-1520 |
Ejemplares similares
-
Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
por: Xie, Dong, et al.
Publicado: (2020) -
Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma
por: Bian, Yun, et al.
Publicado: (2022) -
Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer
por: Yuan, Shu-Qiang, et al.
Publicado: (2017) -
A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma
por: Gao, Jiahao, et al.
Publicado: (2020) -
Radiomics Nomogram in Assisting Lymphadenectomy Decisions by Predicting Lymph Node Metastasis in Early-Stage Endometrial Cancer
por: Liu, Xue-Fei, et al.
Publicado: (2022)